Filing Details

Accession Number:
0000899243-21-007335
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-19 08:44:07
Reporting Period:
2021-02-18
Accepted Time:
2021-02-19 08:44:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1754068 Allovir Inc. ALVR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1681782 R Brett Hagen C/O Allovir, Inc.
139 Main Street, Suite 500
Cambridge MA 02142
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-18 200 $39.36 66,106 No 4 S Direct
Common Stock Disposition 2021-02-18 541 $40.39 65,565 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 6, 2020
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.05 to $39.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.06 to $40.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.